Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ion Dumitru"'
Autor:
Viorica Bumbea, Luminita Ardelean, Luminita Radulescu, Luminita Damian, Horia Bumbea, Ion Dumitru, Claude Lambert, Ana-Maria Vladareanu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundFully mature monocytes that express CD14, but not CD16, undergo phagocytosis within tissues, whereas non-classical monocytes, CD14-low CD16+, represent
Externí odkaz:
https://doaj.org/article/302b714586ee49cda59b3d421bc9276f
Autor:
Elena-Cristina Marinescu, Horia Bumbea, Iuliana Iordan, Ion Dumitru, Dan Soare, Cristina Ciufu, Mihaela Gaman
Publikováno v:
Medicina, Vol 59, Iss 4, p 671 (2023)
Relapsed acute lymphoblastic leukemia (ALL) represents a continuous challenge for the clinician. Despite recent advances in treatment, the risk of relapse remains significant. The clinical, biological, cytogenetic, and molecular characteristics may b
Externí odkaz:
https://doaj.org/article/31bdbace23ec479dab2b1d20ed0dd94e
Publikováno v:
Romanian Medical Journal, Vol 67, Iss 3, Pp 268-276 (2020)
The impact of the importance of regulatory T cells (Treg) in chronic lymphocytic leukemia (CLL) is still controversial and no consensus has been reached on whether the effects generated by these cells are positive or negative in terms of tumor progre
Externí odkaz:
https://doaj.org/article/3d61d7cabde44f3799a0b004bdb7b3d0
Publikováno v:
Romanian Journal of Medical Practice, Vol 14, Iss 3, Pp 325-330 (2019)
Quantification of various cellular subpopulations facilitates the monitoring of hematological diseases, including chronic lymphocytic leukemia. Variations in the proportions of regulatory T cells in peripheral blood have been described in patients
Externí odkaz:
https://doaj.org/article/85e14da1e3484f34ae2c4d7d88e7dd8e
Publikováno v:
Romanian Medical Journal, Vol 66, Iss 2, Pp 132-141 (2019)
In recent years understanding and modulating the tumor microenvironment (MT) has been the focus of a scientifically and clinically intense study. The role of T regulatory cells (Tregs) were investigated in terms of the suppression of tumor-specific
Externí odkaz:
https://doaj.org/article/89dd98097c24476ab2b38d59cd611f1f
Publikováno v:
Romanian Journal of Medical Practice, Vol 12, Iss 4, Pp 234-239 (2017)
Acute leukemias are a group of hematopoietic stem cell malignancies characterized by the proliferation and accumulation of immature cell (blasts) clones that associate medullary insufficiency syndrome (anemia, neutropenia, thrombocytopenia). Dependin
Externí odkaz:
https://doaj.org/article/1e1d1af117274dbd83981c9a3b68a23b
Autor:
Salem, Ahmed, Hofmann, Christian, Ion, Dumitru, Planchart, Carlos, Muzaiyen, Emad, Khalil, Mesbah
Publikováno v:
In Journal of Applied Geophysics February 2020 173
Publikováno v:
Leukemia & Lymphoma. 62:2716-2726
The most frequent mutations in acute myeloid leukemia (AML) – FLT3-ITD and NPM1 – are associated with a specific immunophenotype. We evaluated the levels of surface antigens in an uninvestigated AM...
Autor:
Dan Sebastian Soare, Ana M. Vladareanu, Aurora Arghir, Eugen Radu, Cristina Enache, Horia Bumbea, Ion Dumitru
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 29, Iss 1, Pp 33-41 (2021)
FMS-like tyrosine kinase 3 gene internal tandem (FLT3-ITD) mutations represent one of the most frequent genetic lesions in acute myeloid leukemia (AML) and imparts a negative prognostic. For an optimal patient management, current clinical guidelines
Autor:
Horia Bumbea, Viola Maria Popov, Ciprian Tomuleasa, Meilin Omer, Camelia Dobrea, Irina Manea, Sabina Zurac, Cristiana Popp, Ion Dumitru, Madalina Simoiu, Bogdan Mastalier
Publikováno v:
Cureus.